
Louis Navellier
Editor, Growth InvestorAn icon among growth stock investors
About Louis Navellier
Louis Navellier is one of Wall Street’s renowned growth investors. Providing investment advice to tens of thousands of investors for more than four decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager.
Over his investing career, Louis Navellier has established one of the most exceptional long-term track records of any financial newsletter editor in America, and he offers a wide range of simple yet powerful tools that can help all investors to significantly beat the market.
His popular Growth Investor advisory service, established in 1998, has outperformed the S&P 500 by a margin of 2-to-1.
Navellier continues to build on those stellar records, and while his methodology is rigorous and complex, his goal has been simple since the beginning: uncover the market’s best growth stocks and help investors beat the market with less risk. Today, he helps individual investors across the nation and across the globe achieve their financial dreams through his unique newsletter services.
The New York Times called Mr. Navellier “an icon among growth stock investors,” and the media frequently turns to Louis for his expert opinion. He appears regularly on CNBC and Fox Business News and is frequently quoted by MarketWatch, Bloomberg and The Wall Street Journal.
Navellier is an accomplished Wall Street insider as well. He and his team of professional analysts and staff manage nearly $1 billion in high-net worth funds and institutional accounts through his management company, Navellier & Associates.
Louis Navellier also has a YouTube channel, Navellier Market Buzz, where he posts regular video updates discussing the stock market. He is the author of the bestselling books, The Little Book That Makes You Rich and “The Sacred Truths of Investing.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
Premium Services
Louis Navellier’s Growth Investor provides an expert’s take on the latest market trends and opportunities. Then Louis shares his picks of High-Growth Investments and Elite Dividend Payers — complete with volatility ratings and buy-below prices.
-
Stocks (Mid- to Large-Cap)
-
Conservative
-
Monthly trades
Already a member? Login here
If you want growth, you’ve got to look at smaller up-and-comers that aren’t as well-known... yet. Louis Navellier’s Breakthrough Stocks lets you participate in high-quality small-caps — according to your personal risk tolerance.
-
Stocks (Small to Mid-Cap)
-
Moderate to Aggressive
-
Monthly trades
Already a member? Login here
Accelerated Profits uses Louis Navellier’s proprietary stock-rating system to identify High Velocity and Ultimate Growth Trades. By combining the “one-two punch” of strong momentum and fundamentals with a more frequent trading schedule, you get significant returns... in a fraction of the time.
-
Stocks (Large-Cap)
-
Aggressive
-
Weekly trades
Already a member? Login here
Louis Navellier’s Platinum Growth combines the top-notch investing strategies of Growth Investor and Breakthrough Stocks with the faster pace of Accelerated Profits — all in a powerful new way that could improve your results 10-fold or better.
-
Stocks
-
Conservative to Aggressive
-
Weekly and monthly trades
Already a member? Login here
Recent Articles
3 Great Ways To Play Healthcare (AFAM, MCK, MOH)
Obamacare has begun to enroll millions of uninsured and underinsured in recent years, and that trend will continue, even if Obamacare as we know it is scrapped. These niche healthcare stocks will continue to rally as a result.
3 Great Ways To Play Healthcare (AFAM, MCK, MOH)
Obamacare has begun to enroll millions of uninsured and underinsured in recent years, and that trend will continue, even if Obamacare as we know it is scrapped. These niche healthcare stocks will continue to rally as a result.
Actavis Stock – Buy ACT Now That It’s Acquiring AGN
While Actavis plc (NYSE:ACT) didn't literally start in a garage, it was certainly a humble beginning for what is now the third-largest generic drug manufacturer and one of the largest pharmaceutical companies in the world.
Invest With Extreme Caution in Energy Stocks
I recommend extreme caution when investing in any energy stocks as a lot of systemic risk exists out there in the energy patch.
3 Stocks Rallying After Earnings
While the deflationary environment has made some investors nervous, my long-term outlook for the market remains upbeat.